Cargando…
Reporting of industry funded study outcome data: comparison of confidential and published data on the safety and effectiveness of rhBMP-2 for spinal fusion
Objective To investigate whether published results of industry funded trials of recombinant human bone morphogenetic protein 2 (rhBMP-2) in spinal fusion match underlying trial data by comparing three different data sources: individual participant data, internal industry reports, and publicly availa...
Autores principales: | Rodgers, Mark A, Brown, Jennifer V E, Heirs, Morag K, Higgins, Julian P T, Mannion, Richard J, Simmonds, Mark C, Stewart, Lesley A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687771/ https://www.ncbi.nlm.nih.gov/pubmed/23788229 http://dx.doi.org/10.1136/bmj.f3981 |
Ejemplares similares
-
Off-label use of rhBMP-2
por: Watts, Clark
Publicado: (2011) -
Alveolar cleft defect closure with iliac bone graft, rhBMP-2 and rhBMP-2 with zygoma shavings: Comparative study
por: Balaji, S. M.
Publicado: (2011) -
Quantification of rhBMP2 in bioactive bone materials
por: Lian, Huan, et al.
Publicado: (2020) -
The use of rhBMP in spine surgery: is there a cancer risk?
por: DeVine, John G., et al.
Publicado: (2012) -
Vertical bone regeneration using rhBMP-2 and VEGF
por: Schorn, Lara, et al.
Publicado: (2017)